INTRODUCTION
The family of mitogen-activated protein kinases (MAPKs) is divided into two major groups, extracellular signal-regulated kinases (ERKs) and stress-activated protein kinases (SAPKs). ERKs are mainly activated by growth factors and phorbol esters downstream of the Ras-Raf pathway and, depending on cell type and stimulus, regulate growth or differentiation through direct or indirect phosphorylation of transcription factors [1] . SAPKs are activated during inflammatory processes by cytokines, lysophospholipids, endotoxic lipopolysaccharide, and stress stimuli such as heat and osmotic shock, free radicals, UV light, certain chemicals and protein-synthesis inhibitors [2] . Cellular responses linked to activation of SAPKs by stress stimuli include growth arrest and apoptosis [3] . On the other hand, phosphorylation of heat-shock protein 27 downstream of SAPK2a and MAPKactivated protein kinase-2 (MAPKAP-K2) may play an important role in the repair mechanism after disruption of the actin microfilament network thereby helping cell survival [4] . Several members of the SAPK family, related to HOG1 of Saccharomyces cere isiae, have been described in mammalian tissue : SAPK2a\ CSBP\RK\p38α [4] [5] [6] , SAPK2b\p38β [7] , SAPK3\ERK6\p38γ [8] [9] [10] , SAPK4\p38δ [11, 12] and SAPK5\ERK5 [13] .
The observation that thrombin induces activation of SAPK2a in human platelets was the first example of SAPK regulation downstream of a G protein-coupled receptor [14] . Another physiological platelet stimulus, the matrix protein collagen which Abbreviations used : cPLA 2 , cytosolic phospholipase A 2 ; ERK, extracellular signal-regulated kinase ; MAPK, mitogen-activated protein kinase ; MAPKAP-K2, MAPK-activated protein kinase-2 ; MBP, myelin basic protein ; PD 98059, 2-(2-amino-3-methoxyphenyl)-oxanaphthalen-4-one ; SAPK, stress-activated protein kinase ; SB 203580, 4-(4-fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl) imidazole. 1 To whom correspondence should be addressed at : AG ' Molekulare Zellbiologie ', Klinikum der Friedrich-Schiller Universita$ t Jena, Drackendorfer Str. 1, 07747 Jena, Germany (e-mail v8habe!uni-jena.de).
arachidonic acid induced by the calcium ionophore A23187. This effect was reversed by the inhibitor of SAPK2a, 4-(4-fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl) imidazole (SB 203580), but not by the inhibitor of the ERK2-activating pathway, 2-(2-amino-3-methoxyphenyl)-oxanaphthalen-4-one (PD 98059). Both H # O # and sorbitol increased phosphorylation of cytosolic phospholipase A # (cPLA # ) and its intrinsic activity ; both responses were blocked by SB 203580. Phosphorylation of cPLA # by H # O # occurred on Ser-505, a reaction that is known to increase the intrinsic lipase activity of the enzyme. Our results demonstrate that activation of SAPKs by stress stimuli primes cPLA # activation through phosphorylation. In i o, this mechanism would lead to the sensitization of platelet activation and may be an important risk factor in thrombotic disease.
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activates platelets via a tyrosine-kinase dependent pathway [15, 16] , is also a strong activator of SAPK2a [17] . One major function of SAPK2a in human platelets is the regulation of cytosolic phospholipase A # (cPLA # ) by phosphorylation on Ser-505 [18, 19] , a process that increases the intrinsic activity of the lipase [20, 21] . Activation of cPLA # is the rate-limiting step for the production of thromboxane A # [22] , an important proaggregatory platelet stimulus that underlies secondary platelet activation [23] . Through the use of specific inhibitors of either SAPK2a\2b, 4-(4-fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl) imidazole (SB 203580) [5, 24] , or of the ERK1\2 pathway, 2-(2-amino-3-methoxyphenyl)-oxanaphthalen-4-one (PD 98059) [25] , we have established that cPLA # is regulated downstream of SAPK2a rather than downstream of ERK1\2 in thrombin-and collagen-activated platelets [17, [26] [27] [28] . Similarly, tumour necrosis factor α regulates cPLA # in human neutrophils via SAPK2a [29] . These studies were carried out before the discovery of SAPK2b and, since SB 203580 inhibits both SAPK2a and SAPK2b, this kinase is also a candidate for mediating phosphorylation of cPLA # . Since SAPK2a plays an important role in arachidonic acid release from human platelets, we set out to investigate the effect of several stress stimuli on SAPK activation and arachidonic acid release. We report the sensitization (or priming) of platelets by H # O # and high osmolarity (sorbitol) due to SAPK2a (and\or SAPK2b)-mediated phosphorylation of cPLA # on Ser-505. Priming is not sufficient to stimulate platelets but leads to an enhancement of cPLA # activity and arachidonic acid release in response to the Ca# + -ionophore A23187.
EXPERIMENTAL Reagents
Polyclonal antibodies raised against the whole proteins of SAPK2a and SAPK2b were kindly supplied by Drs R. J. Ulevitch and J. Han (The Scripps Research Institute, La Jolla, CA, U.S.A.). Polyclonal antibodies raised against C-terminal peptides of SAPK2a and SAPK2b, and a polyclonal anti-ERK2 antibody were obtained from Santa Cruz (Devizes, Wilts., U.K.). cPLA # antiserum (R11683) was a gift from Dr C. C. Leslie (National Jewish Medical and Research Center, Denver, CO, U.S.A.) [30] . Polyclonal antibody against MAPKAP-K2 and monoclonal antiphosphotyrosine antibody (4G10) were from UBI (TCS Biologicals Ltd, Bucks., U.K. 
Platelet isolation and stimulation
Blood was drawn from healthy volunteers on the day of the experiment into citrate as anticoagulant, and platelet-rich plasma was obtained by centrifugation at 200 g for 20 min [26] . Platelets were pelleted by centrifugation at 1000 g for 10 min in the presence of 0.1 µg\ml of prostacyclin and washed in 25 ml of Tyrode's buffer (20 mM Hepes, 135 mM NaCl, 3 mM KCl, 0.35 mM Na # HPO % , 12 mM NaHCO $ , 1 mM MgCl # , 5 mM glucose, pH 7.3). Platelets were resuspended in Tyrode's buffer to give a concentration of 4i10) platelets\ml for release studies and 1i10* platelets\ml for immunoprecipitation. Since SB 203580 and PD 98059 are potent inhibitors of cyclooxygenase [31] , platelets were treated with the cyclooxygenase inhibitor indomethacin (10 µM) in all experiments. Platelets were left for 30 min at 30 mC prior to experimentation. Platelet aliquots (250 µl) were prewarmed to 37 mC in the presence of DMSO [0.5 % (w\v), control], SB 203580 (20 µM) or PD 98059 (20 µM). Platelets were activated at 37 mC on a shaking platform or in the aggregometer under stirred conditions (1200 rev.\min). Results were compared with thrombin (1 unit\ml).
Measurement of MAPKAP-K2 activity
After stimulation, platelets were lysed by addition of an equal volume of ice-cold lysis buffer [20 
Measurement of SAPK activity
SAPK2a and SAPK2b were immunoprecipitated from precleared platelet lysates using either 3 µl of polyclonal antiserum raised against the whole proteins or 10 µl (1 µg) of polyclonal antibody raised against specific C-terminal peptides. Immunoprecipitations were carried out under non-denaturing (see above) or denaturing (2 % SDS) conditions as descibed previously [26] .
Immunoprecipitates were washed twice in 20 mM Tris\HCl (pH 7.6) containing 637 mM NaCl, 0.1 % (v\v) Tween 20 and 1 mM EGTA, and twice in 20 mM Tris\HCl (pH 7.6) containing 137 mM NaCl, 0.1 % (v\v) Tween 20 and 1 mM EGTA. After the addition of Laemmli sample buffer, samples were boiled for 10 min and applied on to SDS-polyacrylamide gels (10 % acrylamide), which had 0.4 mg\ml MBP co-polymerized with the acrylamide. After electrophoresis, gels were denatured and renatured as described previously [26] . Gels were incubated in kinase assay buffer (50 mM Tris\HCl, pH 8, 5 mM MgCl # , 1 mM EGTA, 5 mM dithiothreitol, 50 µM ATP and 20 µCi\ml [γ-$#P]ATP for 1 h at 37 mC and washed in 5 % (w\v) trichloroacetic acid containing 1 % (w\v) Na % P # O ( . Gels were dried and autoradiographs were taken over 1-3 days using intensifying screens. For quantification of the signal, gel regions corresponding to SAPKs were excised and radioactivity was determined by Cerenkov counting.
[ 3 H]Arachidonic acid release from platelets
Platelet-rich plasma was labelled with 0.75 µCi\ml of [$H] arachidonic acid for 2 h at 30 mC. Platelets were washed and resuspended in Tyrode's buffer containing 10 µM indomethacin, 3 µM lipoxygenase inhibitor BW4AC [26] and 0.5 % (w\v) BSA. After stimulation, platelets were fixed with an equal volume of 6 % (w\v) glutaraldehyde solution. Samples were centrifuged at 13 000 g for 10 min, and the supernatant was counted for radioactivity by scintillation spectrometry (Beckman) to a 5 % level of significance.
PLA 2 activity in vitro
Stimulation of platelets was terminated by centrifugation at 8000 g for 1 min in a pre-cooled microcentrifuge. Platelet pellets were resuspended in ice-cold sonication buffer (10 mM Hepes, pH 7.4, 140 mM NaCl, 27 mM KCl, 2 mM EGTA, 1 mM dithiothreitol, 1 mM PMSF, 50 mM NaF, 200 µM Na $ VO % , 10 µg\ml leupeptin, 10 µg\ml aprotinin, 10 µM pepstatin A, 1 µM genistein and 1 µM staurosporine). Platelets were sonicated six times, on ice, for 10 s with 30 s intervals. To prepare cytosolic fractions, sonicates were centrifuged at 100 000 g at 4 mC for 1 h. Protein concentration in the supernatant was determined by the Bradford reaction [31a] .
PLA # activity in cytosolic fractions was determined using a method developed from Kramer et al. [32] , in which sonicated liposomes were used as the phospholipid substrate (10 µM phosphatidylcholine, 0.5 µCi\ml of [$H]phosphatidylcholine and 4.83 µM diacylglycerol in 50 mM Hepes, pH 7.5, 150 mM NaCl and 4 mg\ml fatty-acid-free BSA). After incubation of platelet cytosolic fractions with liposomes, lipids were extracted and [$H]arachidonic acid was separated from [$H]phosphatidyl choline using silica gel (pore size 6 nm) as described previously [17] .
Preparation of 32 P-labelled platelets
Washed platelets (1 ml) were labelled with [$#P]P i (20 mCi) at 30 mC for 1.5 h in a phosphate-free buffer (25 mM Hepes, pH 7.3, 145 mM NaCl, 5 mM KCl, 1 mM MgCl # , 10 mM glucose, 10 µM indomethacin). Samples were prepared as described previously [18] . After stimulation, cPLA # was immunoprecipitated from lysates and purified by SDS\PAGE (10 % gel). For analysis of phosphorylation sites, 14 immunoprecipitates from H # O # -stimulated samples were pooled in a single, wide well. Following autoradiography, bands containing cPLA # were excised from the gel and eluted in 50 mM NH % HCO $ containing 0.1 % (w\v) SDS, 1 % (w\v) 2-mercaptoethanol and 20 µg of carrier cPLA # protein, at room temperature over 48 h. Samples were microcentrifuged for 20 min, and the excised gel portions were eluted for a second time for 2 h. Elutes were combined and concentrated to 200 µl. After the addition of 30 µl of trichloroacetic acid (100 %, w\v), samples were left on ice for 2 h to precipitate protein, microcentrifuged for 10 min and the collected protein was washed twice in ice-cold acetone. Protein was dried over a stream of N # and dissolved in 200 µl of freshly-prepared NH % HCO $ (50 mM). Trypsin was added at a trypsin\cPLA # ratio of 1 : 10, and samples were digested at 37 mC for 3 h. The reaction was stopped by cooling the samples to k20 mC. Microbore HPLC was performed on a Vydac 901-3151-00 column (0.5 mmi150 mm ; Michrom BioResources Inc.) as described previously [18] . Synthesized phosphopeptides that correspond to known phosphorylated tryptic peptides of cPLA # were co-injected with the samples. Eluate fractions were collected every 4 min and radioactivity was determined by Cerenkov counting.
Analysis of results
Results from independent experiments are expressed as meanspS.E.M., and n is the number of independent experiments. Homogeneity of variances was tested by means of the F-test, and differences between means were assessed by Student's t test. Statistical significance was assessed at P 0.05.
RESULTS

Effect of stress stimuli on MAPKAP-K2 activity
In order to determine whether stress stimuli activate SAPK cascades in human platelets, we first examined the possible activation of MAPKAP-K2, a substrate in i o for SAPK2a (and possibly SAPK2b) [2] . H # O # caused maximal activation of MAPKAP-K2 between 2 and 5 min of stimulation, peaking at approx. 12-fold the basal level ( Figure 1A ). MAPKAP-K2 activity returned to near basal levels after 15 min, which was probably due to the removal of H # O # by peroxidase activity. In 
Figure 1 Activation of MAPKAP-K2 by stress stimuli
(A) Indomethacin-treated platelets (1i10 9 /ml) were stimulated with 2 mM H 2 O 2 ( ), 0.5 M sorbitol (stirred) ($) or 0.5 mM arsenite (stirred) (>) at 37 mC. MAPKAP-K2 was immunoprecipitated from lysates. Kinase activity was determined using a specific substrate peptide in the presence of 50 µCi/ml of [γ-
32 P]ATP. The peptide was spotted on to filter papers, which were washed and radioactivity was estimated. Data are presented as a percentage of MAPKAP-K2 activation compared with thrombin (1 unit/ml for 2 min), which was taken as 100 %. Typical values for 32 some experiments, H # O # -induced activation of MAPKAP-K2 was already substantially reduced after 5 min of stimulation (for example to 5-fold of basal levels) ( Figure 1B) . Treatment of platelets with a high osmolarity solution (0.5 M sorbitol) slowly increased MAPKAP-K2 activity to a maximum of 5-fold over basal after 15 min of stimulation ( Figure 1A) . Arsenite (0.5 mM), a stimulus that induces ' chemical stress ', caused a steady increase in MAPKAP-K2 activity, which reached approx. 10-fold the basal level after 15 min ( Figure 1A) .
Preincubation of platelets with SB 203580 (20 µM) prevented activation of MAPKAP-K2 by all three stimuli ( Figure 1B ). This concentration of SB 203580 is similar to that required to reduce MAPKAP-K2 activity to below basal levels in the presence of collagen or thrombin, as shown in previous studies [17, 18] . In contrast, preincubation with the specific inhibitor of the ERK1\2-activating pathway, PD 98059, had no significant effect on kinase activity ( Figure 1B) . We have shown previously that 20 µM PD 98059 completely blocked thrombin-, collagen-and phorbol ester-stimulated ERK2 activity [27] . The results of the present work are in agreement with the previous observation that MAPKAP-K2 is a substrate for SAPK2a rather than ERK2 in i o [4] . Activation of MAPKAP-K2 was independent of protein kinase C, as investigated by using the protein kinase C inhibitor Ro 31-8220 (10 µM) (results not shown). Under similar conditions, this concentration of Ro 31-8220 was sufficient to block thrombin-or collagen-induced ERK2 activation as a result of inhibition of protein kinase C [26] .
Activation of SAPKs isoforms
In order to study the activation of SAPK isoforms, we immunoprecipitated these kinases and performed in-gel renaturation kinase assays with MBP as substrate. Since kinases are separated by SDS\PAGE, it is possible to look specifically at SAPK activity ( Figure 2A ) without interference from co-precipitating kinases. This is important, because immunoprecipitation of MAPKs under non-denaturing conditions often results in the coprecipitation of another kinase activity at around 65 kDa, despite high salt washes (Figure 2A ). This kinase was not present in Immunoprecipitates were separated by SDS/PAGE (10 % gel), and autoradiographs were taken. Incorporation of 32 P-label into cPLA 2 was quantified by densitometry (n l 3) and data are expressed as -fold phosphorylation over basal levels. (B) Immunoprecipitates (14) from H 2 O 2 -treated samples (2 min stimulation) were pooled in a single, wide well and sparated by SDS/PAGE (10 % gel). After autoradiography, the portion of the gel containing cPLA 2 was excised and protein was eluted with 20 µg of cPLA 2 carrier protein present. After precipitation and washing, cPLA 2 was digested with trypsin for 3 h at 37 mC. The whole tryptic digest (1700 c.p.m.) was applied on to microbore HPLC and 88 % of the total c.p.m. was recovered. Authentic synthetic phosphopeptides were co-injected with the samples and the retention times were 72.6 min for the Ser-437-containing tryptic fragment (S437-PP) and 92.0 min for the Ser-454-containing tryptic fragment (S454-PP) (shown by arrows). The Ser-727-containing phosphopeptide co-eluted with S454-PP [18] .
the immunoprecipitation performed under denaturing conditions (results not shown).
An antibody raised against the whole SAPK2a protein immunoprecipitated high kinase activity from H # O # -, sorbitol-and arsenite-stimulated human platelets (stimulation time, 5 min), which was less than the kinase activity after stimulation with thrombin for 2 min (Figure 2A) . None of the stress stimuli activated ERK2 (Figure 2A ), whereas thrombin stimulated this kinase, as reported previously [26] . Incubation with H # O # resulted in maximal SAPK2a activation after 2 min, which was higher than the thrombin-induced activation seen after the same time ( Figure 2B ). Activity rapidly declined at longer stimulation intervals returning to near basal levels at 15 min ( Figure 2B ). The time courses of H # O # -induced activation of SAPK2a and MAPKAP-K2 were variable, which might be due to poor stability of the H # O # solution or to differences in the reactivity of platelets prepared from different blood donors. Sorbitol caused a slow and weaker activation of SAPK2a reaching a maximum after 10 min ( Figure 2B ). Similar results were obtained using an antiSAPK2a antibody (Santa Cruz) raised against a unique peptide of the C-terminus of the protein (results not shown). To control for specificity of the antibodies, similar amounts of purified SAPK2a, SAPK2b, SAPK3, SAPK4 and ERK2 were separated by SDS\PAGE, proteins were transferred to a membrane and immunoblotted. Both antibodies against SAPK2a detected purified SAPK2a but none of the other kinases (results not shown).
Stimulation with H # O # for 2 min also induced activation of SAPK2b, as determined using an anti-SAPK2b antibody raised against the full protein (Figure 2A) . The anti-SAPK2b antibody detected purified SAPK2b but not purified SAPK2a, SAPK3, SAPK4 or ERK2 in immunoblots (results not shown).
Phosphorylation of cPLA 2
In order to measure the effect of stress stimuli on cPLA # phosphorylation, cPLA # was immunoprecipitated from $#P-labelled platelets and, after autoradiography, phosphorylation was quantified. Treatment of platelets with H # O # for 5 min increased cPLA # phosphorlyation to 3.7-fold over basal levels, and treatment with sorbitol for 15 min (stirred conditions) induced a 2.7-fold increase of cPLA # phosphorylation over basal levels ( Figure 3A) . By comparison, thrombin (1 unit\ml for 2 min) caused a 4-fold increase in $#P-phosphorylation of cPLA # , whereas the response to collagen (100 µg\ml for 5 min) was similar to the response to sorbitol [33] . H # O # -and sorbitolinduced phosphorylation was reduced to basal levels in the presence of SB 203580 ( Figure 3A) .
In order to determine the sites on cPLA # that become phosphorylated in response to stress stimuli, the phosphorylation sites were mapped using microbore HPLC as described previously [18]. Analysis of trypsin-digested cPLA # that was immunoprecipitated from platelets stimulated for 2 min with H # O # is shown in Figure 3(B) . A single major radioactively-labelled tryptic peptide was eluted at 160-172 min representing 74 % of the label eluted over 60-200 min. It was confirmed that the radioactive tryptic peptide eluting in this region of the chromatogram contains phosphorylated Ser-505. It co-migrated with authentic Ser-505 phosphopeptide obtained by trypsin digestion of cPLA # treated in itro with recombinant MAPK (results not shown). We have shown previously that treatment of cPLA # with ERK2 in itro leads to phosphorylation almost exclusively on Ser-505 [18] . H # O # stimulated very little if any phosphorylation at Ser-437, -454 or -727 ( Figure 3B ). In okadaic acid-stimulated insect cells expressing human cPLA # , these sites have been identified previously as possible phosphorylation sites in addition to Ser-505 [30] .
Arachidonic acid release
Having established that H # O # , sorbitol and arsenite activate SAPKs in human platelets, the effect of these stress stimuli on arachidonic acid release from intact platelets was measured. H # O # , sorbitol and arsenite alone did not cause any significant arachidonic acid release ( 0.1 % above basal). Under stirred conditions, sorbitol slightly enhanced the basal arachidonic acid release to 0.5 % above basal. The lack of stimulation of arachidonic acid release by the stress stimuli, despite marked phosphorylation of cPLA # , most likely reflects the absence of Ca# + mobilization, which is required to translocate cPLA # to membranes [34, 35] . Platelets were, therefore, pre-treated with stress-stimuli and cPLA # activity was stimulated using the Ca# + ionophore A23187. A23187-induced arachidonic acid release is independent of ERK2 or SAPK2a\2b activities [17, 27] . Pretreatment with H # O # (2 mM) resulted in an increase in arachidonic acid release by A23187 over the full dose-response ; this persisted at maximal A23187 concentrations ( Figure 4A ). H # O # (2 mM) increased A23187-induced arachidonic acid release to 118.2p2.8 % (meanpS.E.M., n l 5 independent experiments, P 0.01) compared with the effect of A23187 (10 µM) alone
Figure 6 Tyrosine phosphorylation of platelet proteins
After stimulation with H 2 O 2 or sorbitol, platelets were lysed in sample buffer and proteins were separated by SDS/PAGE (10 % gels). Proteins were transferred on to PVDF membranes and immunoblots were performed using an anti-phosphotyrosine antibody (4G10) and sheep antimouse IgG coupled to horseradish peroxidase. Tyrosine phosphorylated proteins were revealed by enhanced chemiluminescence. The positions of molecular-mass markers (kDa) are shown on the left.
(100 %). Similarly, A23187-induced arachidonic acid release was enhanced by sorbitol (0.5 M) under stirred conditions ( Figure  4B ). At 10 µM A23187 (100 %), sorbitol (0.5 M) increased the response to 124.4p6.5 % (meanpS.E.M., n l 5 independent experiments, P 0.05).
SB 203580 and PD 98059 did not have any significant effect on the A23187-induced arachidonic acid release ( Figure 4C ). Compared with the response elicited by 10 µM A23187 (100 %), the response was 105.1p4.6 % in the presence of SB 203580 and 99.7p7.8 % in the presence of PD 98059 (meanspS.E.M., n l 5 independent experiments, P 0.1). However, the presence of SB 203580 inhibited potentiation of the ionophore response by H # O # , reducing the level of arachidonic acid release to that induced by A23187 alone (Figure 4A ). At 10 µM A23187 (100 %), the inhibition was 90.1p6.5 % (meanpS.E.M., n l 3 independent experiments, P 0.01) when compared with the response to A23187\H # O # . In contrast, PD 98059 did not have any significant effect (114.9p9.4 %, meanpS.E.M., n l 3 independent experiments, P 0.1) when compared with the response to A23187\H # O # . SB 203580 decreased the 10 µM A23187\sorbitol response to 94.9p2.1 % (meanpS.E.M., n l 4 independent experiments, P 0.01), whereas the effect of PD 98059 was not significant (126.5p5.2 ; meanpS.E.M., n l 4 independent experiments, P 0.1). The lack of effect of PD 98059 is in agreement with the lack of activation of ERK2 (Figure 2A) . In contrast to H # O # and sorbitol, pre-treatment with arsenite inhibited A23187-induced arachidonic acid release ( Figure 4D ).
PLA 2 activity in platelets
Since the release of arachidonic acid is regulated by two factors, Ca# + and phosphorylation of cPLA # [36, 37] , cPLA # activity was measured in platelets in itro at a fixed Ca# + concentration. The assay conditions used (presence of reducing agents, 1 µM free Ca# + concentration) ensured that this method was specific for the activity of cPLA # rather than secretory PLA # [17, 21] . Treatment of platelets with H # O # (5 min) increased PLA # activity to 1.6-fold over basal activity, which was similar to the level of activation induced by thrombin ( Figure 5) . Stimulation of platelets with sorbitol for 15 min resulted in a 2.2-fold increase of PLA # activity. Pre-treatment of platelets with SB 203580 reduced the increase in PLA # activity induced by H # O # and sorbitol to basal levels ( Figure 5 ). This is in agreement with our earlier observation that SB 203580 decreased PLA # activity from thrombin-and collagen-treated platelets [17, 28] and suggests that H # O # and sorbitol increase the intrinsic lipase activity through SAPK2a\2b-mediated phosphorylation of cPLA # .
Other platelet responses
In contrast to the activation pattern of SAPKs, sorbitol caused marked overall tyrosine phosphorylation of platelet proteins after 2 min of stimulation whereas H # O # had only a small effect ( Figure 6 ). Arsenite induced a moderate increase in protein tyrosine phosphorylation (results not shown). Protein kinase C was not activated by H # O # or sorbitol as determined by monitoring phosphorylation of the protein kinase C substrate pleckstrin from $#P-labelled platelets (results not shown). None of the stimuli induced aggregation of platelets (results not shown), which is in agreement with their inability to release arachidonic acid on their own. Thus the stress stimuli used in the present study were not sufficient to activate platelets, but had a priming effect which enhanced the arachidonic-acid-release response after stimulation with a Ca# + -releasing agent.
DISCUSSION
The observation by Halenda and co-workers [38, 39] , that phorbol esters synergistically enhance ionophore-stimulated arachidonic acid release in human platelets, suggested a role for protein kinase activity in the regulation of the arachidonic-acid-liberating lipase. This observation was made before the protein sequence of cPLA # and its regulation by intracellular signalling pathways were known. We have shown recently that this response is mediated by ERK2 downstream of protein kinase C [27] . Thus phorbol esters induce a priming effect on arachidonic acid release through the activition of ERK2, which is believed to lead to phosphorylation of cPLA # on Ser-505 [26, 27] . In contrast, the physiological platelet stimuli, thrombin and collagen, induce cPLA # phosphorylation and activation through the SAPK2a (and\or possibly SAPK2b) pathway [17, 28] . Since stress stimuli specifically activate SAPKs, the present study was designed to investigate whether such agents cause an increase in cPLA # activity via the SAPK2a pathway.
Three different stress stimuli were used : H # O # , high osmolarity (sorbitol) and arsenite, all of which led to the activation of the SAPK2a\MAPKAP-K2 pathway (Figures 1 and 2) . In contrast to the sustained responses elicited by sorbitol and arsenite, the responses to H # O # peaked after 2-5 min and returned towards basal levels after 10-15 min of incubation, which was probably due to the enzymic removal of H # O # . None of the stress stimuli activated the ERK2 pathway. Other examples of stimuli that induce selective activation of SAPK2a over ERK2 in human platelets are the thrombin-receptor-activating peptide SFLLRN and low concentrations of arachidonic acid ( 1 µM) [31, 40] . Activation of SAPK2a corresponded to an increase in phosphorylation and intrinsic activity of cPLA # (Figures 3 and  5) . In H # O # -and sorbitol-stimulated platelets, this response was reflected by an enhancement of ionophore-stimulated arachidonic acid release (Figure 4) . The mechanism for this increase in cPLA # activity is probably through phosphorylation of Ser-505, since such phosphorylation is enhanced following H # O # treatment. This is supported by the observation that the increase in cPLA # enzymic activity induced by H # O # , measured in platelet lysates, is comparable with the increase seen when cPLA # is phosphorylated in itro on Ser-505 [20, 41] . We have shown previously that arsenite causes phosphorylation of Ser-505 in HeLa cells [18] , however, in the present study, arsenite reduced arachidonic acid release from intact platelets ( Figure 4D ), presumably due to other toxic actions of this agent. Interestingly, treatment of platelets with H # O # did not lead to phosphorylation of Ser-727 in cPLA # ( Figure 3B ), which is in contrast to stimulation by thrombin and collagen [18] . We speculate that the kinase for this novel phosphorylation site is activated downstream of SAPK2a\2b [18] . Because of the important role of the intracellular Ca# + concentration on arachidonic acid release, it is not possible to draw conclusions on the function of Ser-727 phosphorylation by comparing arachidonic acid release induced by H # O # \ionophore (Ser-505 phosphorylated) with the response induced by thrombin (Ser-505 and -727 phosphorylated).
As a second approach to distinguish between the actions of SAPK2a and ERK2, we included studies with selective inhibitors of the two pathways. SB 203580 and PD 98059 have been tested in itro against a number of kinases, among them protein kinase C, protein kinase A, kinases of the Raf-MAPK\ERK kinase (MEK)-MAPK pathway, the SAPK1\c-Jun kinase and SAPK2a pathway, including MAPKAP-K2 and other downstream kinases, and have been found to be highly specific in their inhibitory action [24, 42] . However, both compounds are potent inhibitors of cyclo-oxygenase-1 and -2, and SB 203580 is also an inhibitor of thromboxane synthase [31] . All experiments, therefore, were conducted in the presence of the cyclo-oxygenase blocker, indomethacin, and thus free arachidonic acid rather than eicosanoid formation was measured. Consistent with the lack of ERK2 activation by stress stimuli, PD 98059, the inhibitor of Raf-MAPK\ERK kinase, had no significant effect on arachidonic acid release ( Figure 4C ). However, the inhibitor of SAPK2a, SB 203580, reduced cPLA # activity to basal levels following treatment with stress stimuli ( Figure 5 ). In intact platelets, it also reversed the stress-induced increase of ionophorestimulated arachidonic acid release ( Figure 4C ). Treatment of platelets with H # O # stimulated not only SAPK2a but also its isoform, SAPK2b, which was described recently [7] . At present, it is not possible to distinguish between the downstream effects of SAPK2a and SAPK2b as SB 203580 inhibits both isoforms with similar IC &! values [2] . In conclusion, our study shows that selective activation of the SAPK2a\2b pathway results in priming of platelets. Upon stimulation with Ca# + -releasing agents, priming leads to an increase in the release of arachidonic acid, the precursor for the secondary platelet stimulus thromboxane A # . Protein kinase C and ERK2 are not involved in this response. The mechanism of activation is likely to be through direct phosphorylation of cPLA # on Ser-505 by SAPK2a or SAPK2b, both of which are inhibited by SB 203580. The priming reaction is of relevance, since activators of SAPK pathways might be present in pathological conditions such as atherosclerosis, ischaemia or thrombosis, and might contribute to the increased platelet reactivity in these conditions.
